Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk

NCT07207564 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4500

Last updated 2026-03-13

No results posted yet for this study

Summary

The purpose of this research is to better understand how benign breast diseases might lead to breast cancer, focusing on genetic factors and including a diverse range of participants to improve future diagnosis and treatment.

Conditions

  • Breast Carcinoma

Interventions

OTHER

Non-Interventional Study

Non-interventional study

Sponsors & Collaborators

Principal Investigators

  • Mark E. Sherman, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-08-28
Primary Completion
2030-06-30
Completion
2030-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07207564 on ClinicalTrials.gov